Filter by: patients
What is montelukast?

Montelukast is used for prophylaxis and chronic treatment of asthma; relief of symptoms of seasonal allergic rhinitis and perennial allergic rhinitis; prevention of exercise-induced bronchospasm.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Asthma 166 38 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Allergies 153 27 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 43 9 Efficacy_major Efficacy_moderate Efficacy_cant_tell
Perennial Allergy 40 5 Efficacy_major Efficacy_moderate Efficacy_cant_tell
Seasonal Allergy 35 2 Efficacy_major Efficacy_moderate
Asthma 27 6 Efficacy_major Efficacy_moderate Efficacy_cant_tell

See all 417 patients currently taking montelukast

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
4
Moderate
4
Mild
9
None
63

Reported Dosages

Frequently reported dosages based on patients currently taking montelukast. See all 15 dosages

  10mg as needed daily 4 mg daily 5 mg daily 8 mg daily 10 other daily 10 mcg daily 10 mg daily 20 mg daily 25 mg daily
  3 Number of Patients: 3 13 Number of Patients: 13 17 Number of Patients: 17 7 Number of Patients: 7 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 370 Number of Patients: 370 3 Number of Patients: 3 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking montelukast (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 19   Did not seem to work: 23%
Expense 19   Expense: 23%
Other 16   Other: 20%
Doctor's advice 13   Doctor's advice: 16%
Side effects too severe 12   Side effects too severe: 15%
Course of treatment ended 8   Course of treatment ended: 10%
Change in health plan coverage 7   Change in health plan coverage: 9%
Personal research 4   Personal research: 5%
Not indicated 1   Not indicated: 1%

See all 79 patients who’ve stopped taking montelukast

Currently Taking montelukast

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking montelukast

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of montelukast

Always
68 85%
Usually
12 15%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of montelukast

Very
1 1%
Somewhat
4 5%
A little
6 8%
Not at all
69 86%

Cost

Paid out of pocket

Cost of montelukast

$200+
0 0%
$100-199
1 2%
$50-99
7 16%
$25-49
14 31%
< $25
23 51%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.